WOWp Zomedica Corp

Zomedica’s Dr. Bonnie Bragdon to Speak at AVMA Convention 2019 on Sunday, August 4

Zomedica’s Dr. Bonnie Bragdon to Speak at AVMA Convention 2019 on Sunday, August 4

ANN ARBOR, Mich., July 25, 2019 (GLOBE NEWSWIRE) -- (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced Dr. Bonnie Bragdon, Vice President of Marketing and Veterinary Affairs, will speak during two sessions at AVMA Convention 2019 on Sunday, August 4, at the Walter E. Washington Convention Center in Washington D.C.

Novel Application of Technology in Diagnostic Testing will take place from 12:00 – 12:20 p.m. in the Convention’s Digital District. The discussion will highlight the challenges veterinarians face in diagnosing and managing canine cancer. Advancements and applications of microfluidics for the detection of circulating tumor cells in human and veterinary medicine will also be featured.

Additionally, Dr. Bragdon will discuss Novel Applications of Technology in Diagnostic Testing: How Cell Phones, Lasers, and Inkjet Printers Will Lead to Advances in Practice from 5:00 – 5:50 p.m. on Sunday, August 4, in room 143BC.

The session will cover topics including the use of Raman spectroscopy and bulk acoustic wave sensors in clinical diagnostics. Raman spectroscopy has been used commercially in drug production and biomedical research for decades. Dr. Bragdon will focus on Zomedica’s application of Raman spectroscopy in pathogen identification and antibiotic stewardship. Additionally, Dr. Bragdon will discuss how bulk acoustic wave sensors can improve immunoassay accuracy in veterinary medicine. Immunoassays are widely used in veterinary medicine to diagnose diseases. Bulk acoustic resonator technology is now cost-effective and can be used to drive improvements in immunoassay accuracy at the point-of-care. Currently, optical and electrical sensors are used, with limitations in performance, to measure binding events that provide results for clinical decision making.

About Zomedica

Based in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) (TSX-V: ZOM) is a veterinary diagnostic and pharmaceutical company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. Zomedica’s product portfolio will include novel diagnostics and innovative therapeutics that emphasize patient health and practice health. With a team that includes clinical veterinary professionals, it is Zomedica’s mission to give veterinarians the opportunity to lower costs, increase productivity, and grow revenue while better serving the animals in their care. For more information, visit .

Follow Zomedica

  • Email Alerts: 
  • LinkedIn: 
  • Facebook: 
  • Twitter: 

Investor Relations Contact:

Shameze Rampertab, CPA, CA



+1 647.283.3630



PCG Advisory Group

Kirin Smith, COO



+1 646.863.6519



Media Contact:

Christy Penka



+1 734.369.2555

EN
25/07/2019

Underlying

WOWpZomedica Corp

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Zomedica Corp

 PRESS RELEASE
Free
WOWp ZOMEDICA CORP

Zomedica Appoints Larry Heaton as President and Announces CEO Successi...

Zomedica Appoints Larry Heaton as President and Announces CEO Succession Plan ANN ARBOR, Mich., Oct. 04, 2021 (GLOBE NEWSWIRE) --  (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostic and therapeutic products for companion animals, today announced that Larry Heaton has been appointed President effective October 1, 2021. Mr. Heaton will assume the role of Chief Executive Officer upon the retirement of current Chief Executive Officer Robert Cohen on October 31, 2021. Following his retirement, Mr. Cohen will remain on the Board of ...

October 4, 2021 1 EN
 PRESS RELEASE
Free
WOWp ZOMEDICA CORP

Zomedica Acquires PulseVet

Zomedica Acquires PulseVet ANN ARBOR, Mich., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostic and therapeutic products for companion animals, today announced that it had acquired the Pulse Veterinary Technologies businesses for $70.9 million in an all-cash, stock transaction. Pulse Veterinary Technologies (“PulseVet”) is a world leader in electro-hydraulic shock wave technology for the treatment of a wide variety of conditions in veterinary patients. The high-energy sound w...

October 1, 2021 1 EN
 PRESS RELEASE
Free
WOWp ZOMEDICA CORP

Sean Whelan Appointed to Board of Directors

Sean Whelan Appointed to Board of Directors ANN ARBOR, Mich., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, announced that Sean Whelan has been appointed to its Board of Directors to fill the vacancy created by the resignation of Christopher Wolfenberg. Robert Cohen, Zomedica’s Chief Executive Officer, commented that: “We all are very pleased to be joined by an executive with Sean’s sterling background. His broad and deep experience and expert...

September 13, 2021 1 EN
 PRESS RELEASE
Free
WOWp ZOMEDICA CORP

Zomedica Announces Second Quarter 2021 Financial Results

Zomedica Announces Second Quarter 2021 Financial Results TRUFORMA® Instrument Placement Program Implemented to Incentivize Future Assay Sales ANN ARBOR, Mich., Aug. 11, 2021 (GLOBE NEWSWIRE) --  (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today reported consolidated financial results for the three and six months ended June 30, 2021. Amounts, unless specified otherwise, are expressed in U.S. dollars and presented under accounting principles generally accepted in the United States of Americ...

August 11, 2021 1 EN
 PRESS RELEASE
Free
WOWp ZOMEDICA CORP

Zomedica Announces 2021 Annual Meeting Results

Zomedica Announces 2021 Annual Meeting Results ANN ARBOR, Mich., July 30, 2021 (GLOBE NEWSWIRE) --  (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for companion animals, today announced the voting results of its 2021 Annual Virtual-Only Meeting of Shareholders (the “Meeting”) held on July 30, 2021. At the Meeting, the Company’s shareholders approved the items of business as follows: Election of Jeffrey Rowe, Robert Cohen, Johnny D. Powers, Rodney Williams, Chris MacLeod and Christopher Wolfenberg as directors; ...

July 30, 2021 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch